Surgery Partners, Inc. (SGRY) Tops Q1 EPS by 7c; Raises 2023 Outlook

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q1 EPS of $0.08, $0.07 better than the analyst estimate of $0.01. Revenue for the quarter came in at $666.2 million versus the consensus estimate of $656.9 million.

GUIDANCE

2023 Outlook

The Company raises projected 2023 Adjusted EBITDA to be greater than $430 million.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge